Misplaced Pages

Revision as of 04:42, 29 December 2009

The neutrality of this article is disputed. Relevant discussion may be found on the talk page. Please do not remove this message until conditions to do so are met. (December 2009) (Learn how and when to remove this message)

Gulf War syndrome (GWS) or Gulf War illness (GWI) affects veterans and civilians who were near conflicts during, or downwind of a chemical weapons depot demolition after, the 1991 Gulf War. A wide range of acute and chronic symptoms have included fatigue, loss of muscle control, headaches, dizziness and loss of balance, memory problems, muscle and joint pain, indigestion, skin problems, immune system problems, and birth defects. Roughly one in four of the 697,000 veterans who served in the first Gulf War are afflicted with the controversial disorder, a real condition with real causes and serious consequences.

Exposure to toxic chemicals is the cause of the illness. Several specific causes have been investigated, including pyridostigmine bromide nerve gas antidote, organophosphate pesticides, chemical weapons, and depleted uranium. Causes which have been ruled out include post traumatic stress disorder, anthrax vaccinations, and smoke from oil well fires. Antidote pills given to protect troops from nerve agents and insect repellents used during deployment were most closely linked. Exposure to the destruction of the Khamisiyah weapons depot, where large quantities of the chemical weapon sarin was stored, is negatively correlated with motor speed. Epidemiological evidence is consistent with increased risk of birth defects in the offspring of persons exposed to depleted uranium.

While the treatment of sarin exposure has been studied, other acetylcholinesterase inhibitors such as pyridostigmine bromide and organophosphate insect repellents may or may not involve similar management. Uranium can be decontaminated from steel surfaces and aquifers. Diplomatic reconciliation is a means of prevention.

Classification

Medial ailments associated with Gulf War Syndrome has been recognized by both the US Department of Defense, Department of Veterans Affairs, and Veterans Administration. Since so little concrete information was known about this condition the Veterans administrations originally classified individuals with related ailments believed to be connected to their service in the Persian Gulf a special non-ICD-9 code DX111, as well as ICD-9 code V65.5.

Signs and symptoms

About one-fourth of the 697,000 U.S. servicemen and women in the first Gulf War have shown symptoms related to Gulf War Syndrome.

U.S. and UK, with the highest rates of excess illness, are distinguished from the other nations by higher rates of pesticide use, use of anthrax vaccine, and somewhat higher rates of exposures to oil fire smoke and reported chemical alerts. France, with possibly the lowest illness rates, had lower rates of pesticide use, and no use of anthrax vaccine. French troops also served to the North and West of all other combat troops, away and upwind of major combat engagements .

A 2001 study of 15,000 February 1991 U.S. Gulf War combat veterans and 15,000 control veterans found that the Gulf War veterans were 1.8 (fathers) to 2.8 (mothers) times more likely to have children with birth defects. After examination of children's medical records two years later, the birth defect rate increased by more than 20%:

"Dr. Kang found that male Gulf War veterans reported having infants with likely birth defects at twice the rate of non-veterans. Furthermore, female Gulf War veterans were almost three times more likely to report children with birth defects than their non-Gulf counterparts. The numbers changed somewhat with medical records verification. However, Dr. Kang and his colleagues concluded that the risk of birth defects in children of deployed male veterans still was about 2.2 times that of non-deployed veterans."

In a study of U.K. troops, "Overall, the risk of any malformation among pregnancies reported by men was 50% higher in Gulf War Veterans (GWV) compared with Non-GWVs."

Although Gulf War illness is the most prominent condition affecting Gulf War veterans, it is just one health issue to be addressed in the larger context of the health of Gulf War veterans. Other Gulf War-related health issues of importance include rates of diagnosable medical conditions and post-war mortality among Gulf War veterans, and questions related to the risk of birth defects and other health problems in veterans’ family members.

The three studies most representative of Gulf War era veterans in the U.S. and U.K. have all indicated significant excess rates of birth defects in children of Gulf War veterans. News articles have reported that rates of cancer and birth defects in Iraq increased dramatically during the 1990s, specifically in regions where the greatest quantity of depleted uranium was used in the Gulf War. Conference reports describing an increased incidence of congenital anomalies in Basrah and increased numbers of cancer cases, both in Iraqi military personnel who served in the war and in four Iraqi hospitals, lend some support to these contentions.

Results from two studies, using different methods in different groups of symptomatic veterans, indicate that Gulf War illness is associated with a low-level, persistent immune activation, reflected in elevated levels of the cytokines IL-2, IFN-γ and IL-10. In addition, several studies have reported that NK cell numbers and/or cytotoxic activity are significantly reduced in veterans with Gulf War illness.

Causes

The United States Congress mandated the National Academies of Science Institute of Medicine to provide nine reports on Gulf War Syndrome since 1998. Aside from the many physical and psychological issues involving any war zone deployment, Gulf War veterans were exposed to a unique mix of hazards not previously experienced during wartime. These included pyridostigmine bromide pills given to protect troops from the effects of nerve agents, depleted uranium munitions, and anthrax and botulinum vaccines. The oil and smoke that spewed for months from hundreds of burning oil wells presented another exposure hazard not previously encountered in a warzone. Military personnel also had to cope with swarms of insects, requiring the widespread use of pesticides.

United States Veterans Affairs Secretary Anthony Principi's panel found that pre-2005 studies suggested the veterans' illnesses are neurological and apparently are linked to exposure to neurotoxins, such as the nerve gas sarin, the anti-nerve gas drug pyridostigmine bromide, and pesticides that affect the nervous system. The review committee concluded that "Research studies conducted since the war have consistently indicated that psychiatric illness, combat experience or other deployment-related stressors do not explain Gulf War veterans illnesses in the large majority of ill veterans," the review committee said.

Pyridostigmine bromide nerve gas antidote

The US military issued pyridostigmine bromide pills, PB, to protect against exposure to nerve gas agents such as sarin and soman. PB was used to pretreat nerve agent poisoning and is not a vaccine however taken before exposure to nerve agents, PB was thought to increase the efficacy of nerve agent antidotes. PB had been used since 1955 for patients suffering from myasthenia gravis with dosed up to 1,500 mg a day, far in excess of the 90 mg given to soldiers, and was considered safe by the FDA at either level for indefinite use and its use to pretreat nerve agent exposure has recently been approved.

About half of U.S. Gulf War veterans report using PB during deployment, with greatest use among Army personnel. Concerns have been raised about the possibility of increased health problems from PB when it is combined with other risk factors.

Given both the large body of epidemiological data on myasthenia gravis patients and follow up studies done on veterans it was concluded that while it was unlikely that health effects reported today by Gulf War veterans are the result of exposure solely to PB, use of PB was causally associated with illness.

Organophosphate pesticides

The use of organophosphate pesticides and insect repellants during the first Gulf War is credited with keeping rates of pest-borne diseases low. Pesticide use is one of only two exposures consistently identified by Gulf War epidemiologic studies to be significantly associated with Gulf War illness. Multisymptom illness profiles similar to Gulf War illness have been associated with low-level pesticide exposures in other human populations. In addition, Gulf War studies have identified dose-response effects, indicating that greater pesticide use is more strongly associated with Gulf War illness than more limited use. Pesticide use during the Gulf War has also been associated with neurocognitive deficits and neuroendocrine alterations in Gulf War veterans in clinical studies conducted follownf the end of the war. The 2008 report concluded that “all available sources of evidence combine to support a consistent and compelling case that pesticide use during the Gulf War is causally associated with Gulf War illness.”

Sarin nerve agent

Many of the symptoms of Gulf War syndrome are similar to the symptoms of organophosphate, mustard gas, and nerve gas poisoning. Gulf War veterans were exposed to a number of sources of these compounds, including nerve gas and pesticides.

Chemical detection units from the Czech Republic, France, and Britain confirmed chemical agents. French detection units detected chemical agents. Both Czech and French forces reported detections immediately to U.S. forces. U.S. forces detected, confirmed, and reported chemical agents; and U.S. soldiers were awarded medals for detecting chemical agents. The Riegle Report said that chemical alarms went off 18,000 times during the Gulf War. After the air war started on January 16, 1991, coalition forces were chronically exposed to low but nonlethal levels of chemical and biological agents released primarily by direct Iraqi attack via missiles, rockets, artillery, or aircraft munitions and by fallout from allied bombings of Iraqi chemical warfare munitions facilities.

In 1997, the US Government released an unclassified report that stated, "The US Intelligence Community (IC) has assessed that Iraq did not use chemical weapons during the Gulf War. However, based on a comprehensive review of intelligence information and relevant information made available by the United Nations Special Commission (UNSCOM), we conclude that chemical warfare (CW) agent was released as a result of US postwar demolition of rockets with chemical warheads at several sites including Khamisiyah". Over 125,000 U.S. troops and 9,000 UK troops were exposed to nerve gas and mustard gas when the Iraqi depot in Khamisiyah was destroyed . "

Recent studies have confirmed earlier suspicions that exposure that sarin, in combination with other contaminants such as pesticides and PB were related to reports of veteran illness. Estimates range from 100,000 to 300,000 individuals exposed to nerve agents

Depleted uranium

Depleted uranium (DU) was widely used in tank kinetic energy penetrator and autocannon rounds for the first time in the Gulf War. DU is a dense, weakly radioactive metal. Munitions made from it often burn when they impact a hard target, producing toxic combustion products. Roughly 320 tons of DU were used during the February, 1991 conflict. After military personnel began reporting unexplained health problems in the aftermath of the Gulf War, questions were raised about the health effect of exposure to depleted uranium.

The use of DU in munitions is controversial because of questions about potential long-term health effects. Normal functioning of the kidney, brain, liver, heart, and numerous other systems can be affected by uranium exposure, because in addition to being weakly radioactive, uranium is a toxic metal. Because uranium is a heavy metal and chemical toxicant with nephrotoxic (kidney-damaging), teratogenic (birth defect-causing), immunotoxic, and potentially carcinogenic properties, uranium exposure is associated with a variety of illnesses. The chemical toxicological hazard posed by uranium dwarfs its radiological hazard because it is only weakly radioactive, and depleted uranium even less so. DU has recently been recognized as a neurotoxin. In 2005, depleted uranium was shown to be a neurotoxin in rats. Epidemiological evidence is consistent with increased risk of birth defects in the offspring of persons exposed to DU.

Early studies of depleted uranium aerosol exposure assumed that uranium combustion product particles would quickly settle out of the air and thus could not affect populations more than a few kilometers from target areas, and that such particles, if inhaled, would remain undissolved in the lung for a great length of time and thus could be detected in urine. Uranyl ion contamination has been found on and around depleted uranium targets.

In 2001, a study was published in Military Medicine that found DU in the urine of Gulf War veterans. Another study, published by Health Physics in 2004, also showed DU in the urine of Gulf War veterans. A study of UK veterans who thought they might have been exposed to DU showed aberrations in their white blood cell chromosomes. Mice immune cells exposed to uranium exhibit abnormalities.

In the Balkans war zone where depleted uranium was also used, an absence of problems is seen by some as evidence of DU munitions' safety. "Independent investigations by the World Health Organization, European Commission, European Parliament, United Nations Environment Programme, United Kingdom Royal Society, and the Health Council of the Netherlands all discounted any association between depleted uranium and leukemia or other medical problems." In Italy, controversy over the health risks associated with the use of DU continues, with a Senate investigation committee was due to release its report into 'Balkan Syndrome' by the end of 2007. Since then, there has been a resurgence of interest in the health effects of depleted uranium, especially since it has recently been linked with neurotoxicity.

The aerosol produced during impact and combustion of depleted uranium munitions can potentially contaminate wide areas around the impact sites or can be inhaled by civilians and military personnel. During a three week period of conflict in 2003 Iraq, 1,000 to 2,000 tonnes of DU munitions were used, mostly in cities. Depleted uranium may have been standard ordnance in the arsenals of both sides during the 2008 South Ossetia war.

Ruled out

Several potential causes beyond vaccinations, stress, and oil well fires—explained in more detail below—have been ruled out. Other ruled-out potential causes include Scud missile fuel and infectious diseases. Limited evidence from several sources suggests that an association with the combined effects of multiple neurotoxicant exposures and receipt of multiple vaccines can not be ruled out.

Anthrax vaccine

Iraq had loaded anthrax, botulinum toxin, and aflatoxin into missiles and artillery shells in preparing for the Gulf War and that these munitions were deployed to four locations in Iraq. During Operation Desert Storm, 41% of U.S. combat soldiers and 75% of UK combat soldiers were vaccinated against anthrax. Like all vaccines, the early 1990s version of the anthrax vaccine was a source of several side effects. Reactions included local skin irritation, some lasting for weeks or months. While the Food and Drug Administration (FDA) approved the vaccine, it never went through large scale clinical trials, unlike most other vaccines in the United States. While recent studies have demonstrated the vaccine’s is highly reactogenic , there is no clear evidence or epidemiological studies on Gulf War veterans linking the vaccine to Gulf War Syndrome. Combining this with the lack of symptoms from current deployments of individuals who have received the vaccine led the Committee on Gulf War Veterans’ Illnesses to conclude that the vaccine is not a likely cause of Gulf War illness for most ill veterans.

Combat stress

Research studies conducted since the war have consistently indicated that psychiatric illness, combat experience or other deployment-related stressors do not explain Gulf War veterans illnesses in the large majority of ill veterans, according to a Veterans Administration review committee.

Oil well fires

During the war, many oil wells were set on fire in Kuwait by the retreating Iraqi army, and the smoke from those fires was inhaled by large numbers of soldiers, many of whom suffered acute pulmonary and other chronic effects, including asthma and bronchitis. However, firefighters who were assigned to the oil well fires and encountered the smoke, but who did not take part in combat, have not had GWI symptoms.

Diagnosis

Multisymptom illness is more prevalent in Gulf War I veterans than veterans of previous conflicts, but the pattern of comorbidities is similar for actively deployed and nondeployed military personnel. Management of potentially comorbid toxic exposures requires awareness of the toxins involved. Exposure to the destruction of the Khamisiyah weapons depot, where large quantities of the chemical weapon sarin was stored, is negatively correlated with motor speed. Epidemiological evidence is consistent with increased risk of birth defects in the offspring of persons exposed to depleted uranium and uranium exposure has also been associated with increased cancer rates.

This section needs expansion. You can help by adding to it.

Management

Diplomatic reconciliation is one means of prevention, beyond battlefield air quality management, which often conflicts with established tactical policy. For example, most organized armies practice "secure and hold" tactics which require occupation of areas before they can be decontaminated.

Acetylcholinesterase inhibitors

Nerve agent antidote and insect repellent

In 2008, a paper published in the Proceedings of the National Academy of Sciences suggested that excess illnesses in Gulf War veterans could be explained in part by their exposure to organophosphate and carbamate acetylcholinesterase inhibitors. A federal report released in November, 2008, agreed, stating that exposure to two substances "are causally associated with Gulf War illness":

• pyridostigmine bromide, an acetylcholinesterase inhibitor intended to protect against nerve agents, and
• pesticides and insect repellents (often acetylcholinesterase inhibitors)

This section needs expansion. You can help by adding to it. (December 2009)

Sarin

Exposure to sarin, a nerve gas, is a possible comorbidity. Chemical weapons classified as nerve agents are also strong acetylcholinesterase inhibitors. A 2004 review discusses symptoms, signs, and treatment of nerve agent exposure.

Uranium exposure

Genotoxic mutagens such as uranium should be treated with chelation therapy or other means shortly after exposure. Incorporated uranium becomes uranyl ions, which accumulate in bone, liver, kidney, and reproductive tissues. Uranium can be decontaminated from steel surfaces and aquifers.

Epidemiology

Epidemiologic studies have been performed evaluating many suspected factors for Gulf War illness as seen in veteran populations. Below is a summary of epidemiologic studies of veterans displaying multisymptom illness and their exposure to suspect conditions from the 2008 U.S. Veterans Administration report.

A fuller understanding of immune function in ill Gulf War veterans is needed, particularly in veteran subgroups with different clinical characteristics and exposure histories. It is also important to determine the extent to which identified immune perturbations may be associated with altered neurological and endocrine processes that are associated with immune regulation. No studies that have evaluated birth outcomes and birth defects among Gulf War veterans and their children have assessed whether there is any connection between reproductive outcomes and uranium exposure in the Gulf War. Very limited cancer data have been reported for U.S. Gulf War veterans in general, and no published research on cases occurring after 1999. Because of the extended latency periods associated with most cancers, it is important that cancer information be brought up to date and that cancer rates be assessed in Gulf War veterans on an ongoing basis. In addition, cancer rates should be evaluated in relation to identifiable exposure and location subgroups.

Controversy

Similar syndromes have been seen as an after effect of other conflicts — for example, 'shell shock' after World War I, and post-traumatic stress disorder (PTSD) after the Vietnam War. A review of the medical records of 15,000 American Civil War soldiers showed that "those who lost at least 5% of their company had a 51% increased risk of later development of cardiac, gastrointestinal, or nervous disease."

A November 1996 article in the New England Journal of Medicine found no difference in death rates, hospitalization rates or self-reported symptoms between Persian Gulf veterans and non-Persian Gulf veterans. This article was a compilation of dozens of individual studies involving tens of thousands of veterans. The study did find a statistically significant elevation in the number of traffic accidents suffered by Gulf War veterans. An April, 1998 article in Emerging Infectious Diseases similarly found no increased rate of hospitalization and better health overall for veterans of the Persian Gulf War vs. Veterans who stayed home.

Despite these studies, on November 17, 2008 a congressionally appointed committee called the Research Advisory Committee on Gulf War Veterans' Illnesses, staffed with independent scientists and veterans appointed by the Department of Veterans Affairs, announced that the syndrome is a distinct physical condition. The committee recommended that Congress increase funding for research on Gulf War veterans' health to at least $60 million per year. In January 2006, a study led by Melvin Blanchard and published by the Journal of Epidemiology, part of the "National Health Survey of Gulf War-Era Veterans and Their Families", stated that veterans deployed in the Persian Gulf War had nearly twice the prevalence of chronic multisymptom illness, a cluster of symptoms similar to a set of conditions often called Gulf War Syndrome.

See also

• Beyond Treason an 89-minute 2005 documentary that covers the Gulf War syndrome.
• Environmental issues with war

References

1. Iversen A, Chalder T, Wessely S. "Gulf War Illness: lessons from medically unexplained symptoms." Clin Psychol Rev. 2007 Oct;27(7):842-54.
2. Gronseth GS. "Gulf war syndrome: a toxic exposure? A systematic review." Neurol Clin. 2005 May;23(2):523-40.
3. University of Virginia. Gulf War Syndrome
4. ^ Gulf War Illness and Health of Gulf War Veterans
5. ^ Toomey et al (2009) "Neuropsychological functioning of U.S. Gulf War veterans 10 years after the war" J Int Neuropsychol Soc PMID 19640317
6. ^ Hindin, R. et al. (2005) "Teratogenicity of depleted uranium aerosols: A review from an epidemiological perspective," Environmental Health, vol. 4, pp. 17. at PubMed
7. ^ Schecter, WP (2004) "Cholinergic symptoms due to nerve agent attack: a strategy for management." Anesthesiol Clin North America 22(3):579-90. PMID 15325720
8. ^ Francis, A.J. (2005) "Decontamination of uranium-contaminated steel surfaces by hydroxycarboxylic acid with uranium recovery." Environ Sci Technol 39(13):5015-21. PMID 16053105
9. ^ Wu, W.M. et al (2006) "Pilot-scale in situ bioremedation of uranium in a highly contaminated aquifer. 2. Reduction of u(VI) and geochemical control of u(VI) bioavailability." Environ Sci Technol 40(12):3986-95. PMID 16830572
10. ^ Curle, A. (1997) "Public mental health. III: Hatred and reconciliation." Med Confl Surviv 13(1):37-47. PMID 9080785
11. ^ Jentleson, B.W. (1996) "Preventive Diplomacy and Ethnic Conflict: Possible, Difficult, Necessary" UC Berkeley Policy Paper 27, Institute on Global Conflict and Cooperation
12. Gulf War Veterans' Illnesses: Illnesses Associated with Gulf War Service
13. Department of Veterans Affairs A Guide to Gulf War Veterans' Health
14. Research Advisory Committee on Gulf War Veterans’ Illnesses December 12-13, 2005 Committee Meeting Minutes (page 78)
15. Research Advisory Committee on Gulf War Veterans’ Illnesses December 12-13, 2005 Committee Meeting Minutes (page 68)
16. Kang, H.; et al. (2001). "Pregnancy Outcomes Among U.S. Gulf War Veterans: A Population-Based Survey of 30,000 Veterans". Annals of Epidemiology. 11 (7): 504–511. doi:10.1016/S1047-2797(01)00245-9. PMID 11557183. {{cite journal}}: Explicit use of et al. in: |author= (help); Italic or bold markup not allowed in: |journal= (help)
17. Department of Veterans Affairs (2003) "Q's & A's - New Information Regarding Birth Defects," Gulf War Review 12(1), p. 10.
18. Doyle, P., et al. (2004) "Miscarriage, stillbirth and congenital malformation in the offspring of UK veterans of the first Gulf war," International Journal of Epidemiology, 33(1), pp. 74-86; PMID 15075150.
19. Research Advisory Committee on Gulf War Veterans’ Illnesses December 12-13, 2005 Committee Meeting Minutes (page 70), This table applies only to coalition forces involved in combat.
20. I. Al-Sadoon, et al., writing in the Medical Journal of Basrah University, (see Table 1 here). This version from data by same author(s) in Wilcock, A.R., ed. (2004) "Uranium in the Wind" (Ontario: Pandora Press) ISBN 097361532X
21. Research Advisory Committee on Gulf War Veterans’ Illnesses December 12-13, 2005 Committee Meeting Minutes (page 71)
22. ^ Page 262 (PDF page 270) of the November, 2008 U.S. Veterans Administration report
23. VA Press Release
24. Research Advisory Committee on Gulf War Veterans’ Illnesses 2004 Report
25. PBS Frontline. PYRIDOSTIGMINE BROMIDE Use in the First Gulf War
26. U.S. Department of Defense, Office of the Special Assistant to the Undersecretary of Defense (Personnel and Readiness) for Gulf War Illnesses Medical Readiness and Military Deployments. Environmental Exposure Report: Pesticides Final Report. Washington, D.C. April 17, 2003.
27. Krengel M, Sullivan K. Neuropsychological Functioning in Gulf War Veterans Exposed to Pesticides and Pyridostigmine Bromide. Fort Detrick, MD: U.S. Army Medical Research and Materiel Command; August, 2008. W81XWH-04-1-0118
28. Friis, Robert H. (2004). Epidemiology for Public Health Practice. Jones & Bartlett Publishers. ISBN 0763731706. {{cite book}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
29. Spektor, Dalia M. (1998). A Review of the Scientific Literature as it Pertains to Gulf War Illnesses. Rand Corporation. ISBN 0833026801. {{cite book}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
30. "Campaigners hail 'nerve gas link' to Gulf War Syndrome - Scotsman.com News". News.scotsman.com. Retrieved 2009-11-24.
31. The Riegle Report
32. Khamisiyah: A Historical Perspective on Related Intelligence by the Persian Gulf War Illnesses Task Force (9 April 1997)
33. Beatrice Alexandra Golomb.Acetylcholinesterase inhibitors and Gulf War illnesses
34. Navy Times. Review says chemicals caused Gulf War illness
35. ^ Global Security. ``Depleted Uranium``
36. Miller AC, McClain D. (2007 Jan-Mar). "A review of depleted uranium biological effects: in vitro and in vivo studies". Rev Environ Health. 22 (1): 75–89. PMID 17508699. {{cite journal}}: Check date values in: |year= (help); Italic or bold markup not allowed in: |journal= (help)CS1 maint: year (link)
37. E. S. Craft, A. W. Abu-Qare, M. M. Flaherty, M. C. Garofolo, H. L. Rincavage, M. B. Abou-Donia (2004). "Depleted and natural uranium: chemistry and toxicological effects". Journal of Toxicology and Environmental Health Part B: Critical Reviews. 7 (4): 297–317. doi:10.1080/10937400490452714. {{cite journal}}: Italic or bold markup not allowed in: |journal= (help)CS1 maint: multiple names: authors list (link)
38. Health effects of uranium
39. Hindin R, Brugge D, Panikkar B (2005). "Teratogenicity of depleted uranium aerosols: a review from an epidemiological perspective". Environ Health. 4: 17. doi:10.1186/1476-069X-4-17. PMID 16124873. {{cite journal}}: Italic or bold markup not allowed in: |journal= (help)CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link)
40. Arfsten D, Still K, Ritchie G (2001). "A review of the effects of uranium and depleted uranium exposure on reproduction and fetal development". Toxicol Ind Health. 17 (5–10): 180–91. doi:10.1191/0748233701th111oa. PMID 12539863.{{cite journal}}: CS1 maint: multiple names: authors list (link)
41. Wan B, Fleming J, Schultz T, Sayler G (2006). "In vitro immune toxicity of depleted uranium: effects on murine macrophages, CD4+ T cells, and gene expression profiles". Environ Health Perspect. 114 (1): 85–91. PMID 16393663.{{cite journal}}: CS1 maint: multiple names: authors list (link)
43. ATSDR - Toxicological Profile: Uranium
44. ^ Jiang G, Aschner M (2006). "Neurotoxicity of depleted uranium: reasons for increased concern". Biol Trace Elem Res. 110 (1): 1–17. doi:10.1385/BTER:110:1:1. PMID 16679544. {{cite journal}}: Italic or bold markup not allowed in: |journal= (help)
45. Anandan N, Shetty S, Patil K, Ibrahim A (1992). "Acute urinary retention caused by anterior urethral polyp". Br J Urol. 69 (3): 321–2. doi:10.1111/j.1464-410X.1992.tb15541.x. PMID 1568112. {{cite journal}}: Italic or bold markup not allowed in: |journal= (help)CS1 maint: multiple names: authors list (link)
47. Mitsakou C, Eleftheriadis K, Housiadas C, Lazaridis M (2003). "Modeling of the dispersion of depleted uranium aerosol". Health Phys. 84 (4): 538–44. doi:10.1097/00004032-200304000-00014. PMID 12705453.{{cite journal}}: CS1 maint: multiple names: authors list (link)
48. Horan P, Dietz L, Durakovic A (2002). "The quantitative analysis of depleted uranium isotopes in British, Canadian, and U.S. Gulf War veterans". Mil Med. 167 (8): 620–7. PMID 12188230.{{cite journal}}: CS1 maint: multiple names: authors list (link)
49. Salbu B, Janssens K, Lind O, Proost K, Gijsels L, Danesi P (2005). "Oxidation states of uranium in depleted uranium particles from Kuwait". J Environ Radioact. 78 (2): 125–35. doi:10.1016/j.jenvrad.2004.04.001. PMID 15511555.{{cite journal}}: CS1 maint: multiple names: authors list (link)
50. Hodge S, Ejnik J, Squibb K, McDiarmid M, Morris E, Landauer M, McClain D (2001). "Detection of depleted uranium in biological samples from Gulf War veterans". Mil Med. 166 (12 Suppl): 69–70. PMID 11778443.{{cite journal}}: CS1 maint: multiple names: authors list (link)
51. Gwiazda R, Squibb K, McDiarmid M, Smith D (2004). "Detection of depleted uranium in urine of veterans from the 1991 Gulf War". Health Phys. 86 (1): 12–8. doi:10.1097/00004032-200401000-00004. PMID 14695004.{{cite journal}}: CS1 maint: multiple names: authors list (link)
52. Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 12678382, please use {{cite journal}} with |pmid=12678382 instead.
53. Wan B, Fleming J, Schultz T, Sayler G (2006). "In vitro immune toxicity of depleted uranium: effects on murine macrophages, CD4+ T cells, and gene expression profiles". Environ Health Perspect. 114 (1): 85–91. PMID 16393663.{{cite journal}}: CS1 maint: multiple names: authors list (link)
54. Anes Alic (October 29, 2007). "Depleted uranium, depleted health concerns". ISN Security Watch.
55. Mitsakou C, Eleftheriadis K, Housiadas C, Lazaridis M Modeling of the dispersion of depleted uranium aerosol. 2003 Apr, Retrieved January 15, 2009
56. Paul Brown, Gulf troops face tests for cancer guardian.co.uk 25 April 2003, Retrieved February 3, 2009
57. Veterans Administration (November, 2009) p. 11 (PDF page 21)
58. Anthony H. Cordesman. Iraq and the War of Sanctions: Conventional Threats and Weapons of Mass Destruction
59. Research Advisory Committee on Gulf War Veterans’ Illnesses December 12-13, 2005 Committee Meeting Minutes (page 73.)
60. GAO-01-92T Anthrax Vaccine: Preliminary Results of GAO's Survey of Guard/Reserve Pilots and Aircrew Members
61. The Clarion-Ledger: Mississippi's News Source
62. Pharmacoepidemiology and Drug Safety.Short-term reactogenicity and gender effect of anthrax vaccine: analysis of a 1967-1972 study and review of the 1955-2005 medical literature
63. Research Advisory Committee on Gulf War Veterans’ Illnesses December 12-13, 2005 Committee Meeting Minutes (pages 148, 154, 156)
64. Kelsall et al (2009) "Physical, psychological, and functional comorbidities of multisymptom illness in Australian male veterans of the 1991 Gulf War," Am J Epidemiol 170(8):1048-56. PMID 19762370
65. The History of Uranium Mining and the Navajo People
66. Lung Cancer in a Nonsmoking Underground Uranium Miner
67. Uranium mining and lung cancer in Navajo men
68. Navajo Uranium Workers and the Effects of Occupational Illnesses: A Case Study
69. Uranium Mining and Lung Cancer Among Navajo Men in New Mexico and Arizona, 1969 to 1993
70. Lung cancer among Navajo uranium miners.
71. Golomb, B. (2008) "Acetylcholinesterase inhibitors and Gulf War illnesses" Proc Natl Acad Sci; Reuters; MedPageToday.com
72. "Gulf War illness is real, new federal report says" on CNN
73. Research Advisory Committee on Gulf War Veterans’ Illnesses December 12-13, 2005 Committee Meeting Minutes
74. Sawicki, M; Lecerclé, D; Grillon, G; Le Gall, B; Sérandour, AL; Poncy, JL; Bailly, T; Burgada, R; Lecouvey, M (2008). "Bisphosphonate sequestering agents. Synthesis and preliminary evaluation for in vitro and in vivo uranium(VI) chelation". European journal of medicinal chemistry. 43 (12): 2768–77. doi:10.1016/j.ejmech.2008.01.018. PMID 18313802.
75. Spagnul, A et al (2009) "Calixarene-entrapped nanoemulsion for uranium extraction from contaminated solutions." J Pharm Sci PMID 19780139
76. Gulf War Illness and Health of Gulf War Veterans (page 220-221)
77. Page 96 (PDF page 105) of the November, 2008 U.S. Veterans Administration report
78. Page 45 (PDF page 55) of the November, 2008 U.S. Veterans Administration report
79. Gulf War Illness and Health of Gulf War Veterans (page 222)
80. Attention: This template ({{cite doi}}) is deprecated. To cite the publication identified by doi:10.1126/science.291.5505.812, please use {{cite journal}} (if it was published in a bona fide academic journal, otherwise {{cite report}} with |doi=10.1126/science.291.5505.812 instead.
81. New England Journal of Medicine. Disease and Suspicion after the Persian Gulf War. Volume 335:1525-1527, November 14, 1996
82. Knoke JD, Gray GC (1998). "Hospitalizations for unexplained illnesses among U.S. veterans of the Persian Gulf War" (PDF). Emerging Infect. Dis. 4 (2): 211–9. PMC 2640148. PMID 9621191.
83. News Services, "Gulf War Syndrome Is Real, Panel Concludes", Washington Post, November 18, 2008, p. 14.
84. Record: Study finds multisymptom condition is more prevalent among Persian Gulf vets

External links

Research

• Research Advisory Committee on Gulf War Veterans' Illnesses, publishers of the 2008 Gulf War Illness and the Health of Gulf War Veterans: Scientific Findings and Recommendations (7.4 MB PDF)
• Uranium Medical Research Centre, founded in 1997 by Dr. Asaf Durakovic, M.D., formerly Chief of Professional Clinical Services in the U.S. Army's 531st Medical Detachment during the Desert Shield phase of the 1991 Gulf War and former Veteran's Administration official

Associations

• American Gulf War Veterans Association
• National Gulf War Resource Center
• Veterans of Modern Warfare

Video

• Conspiracy Test: Gulf War Illness investigative report by the Discovery Channel - part 1, part 2, part 3, part 4, part 5

• Articles with dead external links from April 2008
• Misplaced Pages neutral point of view disputes from December 2009
• Gulf War syndrome
• Genetic disorders
• Immune system disorders
• Military personnel
• Neurological disorders
• Syndromes
• Gulf War